What’s New and What’s Next

The line between patient privacy and pharma marketing isn’t new, but the consequences of getting it wrong are becoming harder to ignore.

How Oar Health achieved sustainable member growth without significantly increasing CAC or relying on paid search.

Transform black-box enrollment platforms into your best-performing channel with privacy-safe BOFU signals, smarter remarketing, and lower cost-per-enrollment before AEP/OEP.

An honest look at how the market, the product, and the sales motion have evolved

Freshpaint's latest updates give healthcare marketers a clearer picture of what's actually driving results without sacrificing compliance.

Mina promoted from Chief Marketing Officer to lead next phase of privacy-fueled performance in healthcare marketing

Discover the hidden “re-acquisition tax” draining your healthcare marketing budget—and how multi-channel strategies turn patients into loyal return visits.

Trust, privacy, and brand are what separate the healthcare marketers winning in 2026 from everyone else.

Healthcare data privacy extends far beyond HIPAA. Learn how the FTC, state privacy laws, and the My Health My Data Act regulate health information for non-covered entities—and what marketers need to know to stay compliant.

Meta’s health data crackdown is already eroding pharma performance, and teams that don’t adapt will see costs rise and results fall.

Why signal loss, rising costs, and privacy pressure demand a new model.

Freshpaint Consent Manager enforces consent automatically, state by state, across your marketing stack.